1Houman FM,Lopes RD,Stashenko GJ,et al. Threatment of ve-nous thromboembolism : guidelines translated for the clinician [J].Thromb Thrombolysis,2009,28(3) :270-275.
2Kahn SR,Shrier I,Julian JA,et al. Determinants and time courseof the postthrombotic syndrome after acute deep venous thrombo-sis[J]. Annlntem Med,2008,149( 10) ;698-707.
3Karthikesalingam A,Young EL,Hinchliffe RJ,et al. A systematicreview of percutaneous mechanical thrombectomy in the treatmentof deep venous thrombosxs[J]. Eur J Vase Endovasc Surg,2011,41(4):554-565.
4Enden T,Haig Y,Klow NE,et al. Long-term outcome after addi-tional catheter-directed thrombolysis versus standard treatmentfor acute iliofemoral deep vein thrombosis (the CaVenT study) :arandomised controlled trial[J]. Lancet,2012,379(9810) :31-38.
5Strijkers RH,Cate-Hoek AJ,Bukkems SF,et al. Management ofdeep vein thrombosis and prevention of post-thrombotic syndro-me[J]. BMJ’2011’343: 5916.
6Vo T, Vazquez S,Rondina MT. Current state of anticoagulants totreat deep venous thrombosis[J]. Curr Cardiol Rep,2014,16(3) :463.
7Tagalakis V,Patenaude V,Kahn SR,et al. Incidence of and mor-tality from venous thromboembolism in a real-world population:the Q-VTE Study CohortfJ]. Am J Med,2013,126(9) :el3-21.
8Comerota AJ, Kamath V. Thrombolysis for iliofemoral deep ve-nous thrombosis[J]. Expert Rev Cardiovasc Ther,2013,11( 12):1631-1638.
9Blondon M,Righini M, Aujesky D,et al. Usefulness of preemp-tive anticoagulationin patients with suspected pulmonary embo-lism :a decision analysisfj]. Chest,2013,9(372) : 306-308.
10Vedantham S, Thorpe PE, Cardella JF,et al. Quality improvementguidelines for the treatment of lower extremity deep vein throm-bosis with use of endovascular thrombus removal [J]. J Vase IntervRadiol,2009,20(7 Suppl) :S227-239.